Stay updated with breaking news from 09769810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,960,000 shares, an increase of 12.6% from the February 29th total of 1,740,000 shares. Currently, 8.2% of the shares of the stock are short sold. Based […]
HC Wainwright reiterated their buy rating on shares of Bolt Biotherapeutics (NASDAQ:BOLT – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $8.00 target price on the stock. HC Wainwright also issued estimates for Bolt Biotherapeutics’ Q1 2024 earnings at ($0.47) EPS, Q2 2024 earnings at […]
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) major shareholder Vivo Capital Viii, Llc sold 54,700 shares of the firm’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $0.92, for a total transaction of $50,324.00. Following the completion of the sale, the insider now owns 113,119 […]
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 1,650,000 shares, an increase of 5.8% from the September 30th total of 1,560,000 shares. Based on an average daily trading volume, of 116,100 […]
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.42 and traded as low as $1.01. Bolt Biotherapeutics shares last traded at $1.03, with a volume of 78,732 shares. Analysts Set […]